We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+35.87%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$179M
AUM Growth
-$219M
Cap. Flow
-$249M
Cap. Flow %
-138.94%
Top 10 Hldgs %
17.69%
Holding
1,341
New
343
Increased
62
Reduced
166
Closed
769

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.1%
2 Technology 14.59%
3 Industrials 13.7%
4 Financials 11.48%
5 Communication Services 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CASS icon
251
Cass Information Systems
CASS
$743M
$243K 0.14%
6,221
-10,384
-63% -$390K
SFNC icon
252
Simmons First National
SFNC
$3.39B
$243K 0.14%
+14,206
New +$243K
KEYS icon
253
Keysight
KEYS
$58.3B
$242K 0.13%
2,401
-2,344
-49% -$230K
KLIC icon
254
Kulicke & Soffa
KLIC
$4.78B
$241K 0.13%
+11,575
New +$262K
NVO
255
Novo Nordisk
NVO
$209B
$241K 0.13%
+7,376
New +$235K
POWI icon
256
Power Integrations
POWI
$3.6B
$241K 0.13%
+4,074
New +$214K
AEL
257
DELISTED
American Equity Investment Life Holding Company
AEL
$241K 0.13%
9,773
-8,191
-46% -$171K
CTT
258
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$241K 0.13%
27,236
-25,102
-48% -$194K
BMCH
259
DELISTED
BMC Stock Holdings, Inc
BMCH
$241K 0.13%
9,587
-18,861
-66% -$417K
CPLG
260
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
$239K 0.13%
+56,743
New +$222K
AMRX icon
261
Amneal Pharmaceuticals
AMRX
$5.79B
$238K 0.13%
49,901
-48,338
-49% -$199K
FPI
262
Farmland Partners
FPI
$432M
$238K 0.13%
+34,713
New +$228K
NXST icon
263
Nexstar Media Group
NXST
$5.92B
$238K 0.13%
+2,839
New +$214K
OFIX icon
264
Orthofix Medical
OFIX
$419M
$237K 0.13%
+7,418
New +$246K
ERIC icon
265
Ericsson
ERIC
$33.3B
$236K 0.13%
+25,389
New +$220K
LCII icon
266
LCI Industries
LCII
$2.65B
$236K 0.13%
+2,050
New +$189K
TIGO icon
267
Millicom
TIGO
$16.3B
$236K 0.13%
+9,028
New +$234K
AXDX
268
DELISTED
Accelerate Diagnostics
AXDX
$235K 0.13%
+1,551
New +$153K
RSG icon
269
Republic Services
RSG
$66B
$235K 0.13%
2,867
-2,600
-48% -$210K
JCI icon
270
Johnson Controls International
JCI
$92.2B
$234K 0.13%
+6,862
New +$211K
CAG icon
271
Conagra Brands
CAG
$7.23B
$233K 0.13%
6,618
-4,108
-38% -$137K
RCUS icon
272
Arcus Biosciences
RCUS
$3.64B
$233K 0.13%
9,417
-23,902
-72% -$645K
NPTN
273
DELISTED
NEOPHOTONICS CORP
NPTN
$232K 0.13%
26,148
-38,750
-60% -$334K
AT
274
DELISTED
Atlantic Power Corporation
AT
$231K 0.13%
115,631
+93,790
+429% +$187K
PRNB
275
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$231K 0.13%
+3,861
New +$239K

Similar funds

GSA Capital Partners's Q2 2020 Portfolio in Review

As of Q2 2020, GSA Capital Partners held 1,341 positions worth $179M, down 55% from $399M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

GSA Capital Partners withdrew a net $249M in Q2 2020, closing 769 positions and reducing 166 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $26M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

Against the trend, GSA Capital Partners opened a new position in Nebius Group N.V. worth $7.34M.

  • GSA Capital Partners's largest Q2 2020 buy was Nebius Group N.V.: 146,789 shares worth $7.34M.
  • GSA Capital Partners added most to Micron Technology in Q2 2020, an estimated $1.56M increase.
  • GSA Capital Partners's biggest Q2 2020 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $26.9M.
  • GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, selling an estimated $26M.
  • GSA Capital Partners's ten largest holdings make up 18% of its $179M portfolio in Q2 2020.
  • GSA Capital Partners opened 343 new positions and closed 769 in Q2 2020.
  • GSA Capital Partners's portfolio value fell 55% quarter-over-quarter to $179M.

Based on GSA Capital Partners's 13F filing for Q2 2020, filed 11 Aug 2020.